[go: up one dir, main page]

ES8801280A1 - Procedimiento para la obtencion de benzo-(pirano y tiopirano)-piridinas - Google Patents

Procedimiento para la obtencion de benzo-(pirano y tiopirano)-piridinas

Info

Publication number
ES8801280A1
ES8801280A1 ES555528A ES555528A ES8801280A1 ES 8801280 A1 ES8801280 A1 ES 8801280A1 ES 555528 A ES555528 A ES 555528A ES 555528 A ES555528 A ES 555528A ES 8801280 A1 ES8801280 A1 ES 8801280A1
Authority
ES
Spain
Prior art keywords
lower alkyl
hydroxy
mono
amino
acylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES555528A
Other languages
English (en)
Other versions
ES555528A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES555528A0 publication Critical patent/ES555528A0/es
Publication of ES8801280A1 publication Critical patent/ES8801280A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06Benzothiopyrans; Hydrogenated benzothiopyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE BENZO(PIRANO Y TIOPIRANO)-PIRIDINAS, DE FORMULA GENERAL (I), Y DE SUS SALES FARMACEUTICAMENTE ACEPTABLES. CONSISTE EN REDUCIR UN COMPUESTO DE FORMULA GENERAL (II) CON UN AGENTE REDUCTOR DE HIDROGENACION SENCILLO O COMPLEJO, EN CASO DADO EN PRESENCIA DE UN ACIDO LEWIS. LA REDUCCION SE LLEVA A EFECTO BAJO PROTECCION INTERMEDIA DE LOS GRUPOS FUNCIONALES CAPACES DE REACCION, CUYA REACTIVIDAD PUDIERA REPERCUTIR DE MANERA PERTURBADORA. EL COMPUESTO DE FORMULA GENERAL (I) OBTENIDO SE AISLA DESPUES DE LA CORRESPONDIENTE DISOCIACION DE LOS GRUPOS PROTECTORES. DE APLICACION COMO MEDIOS NEUROLEPTICOS PARA EL TRATAMIENTO DE ESTADOS PSICOTICOS O COMO MEDIOS ANTIDEPRESIVOS PARA EL TRATAMIENTO DE DEPRESIONES.
ES555528A 1984-05-10 1986-05-30 Procedimiento para la obtencion de benzo-(pirano y tiopirano)-piridinas Expired ES8801280A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60903784A 1984-05-10 1984-05-10

Publications (2)

Publication Number Publication Date
ES555528A0 ES555528A0 (es) 1988-01-01
ES8801280A1 true ES8801280A1 (es) 1988-01-01

Family

ID=24439108

Family Applications (5)

Application Number Title Priority Date Filing Date
ES542929A Expired ES8706687A1 (es) 1984-05-10 1985-05-08 Procedimiento para la obtencion de benzo-(pirano y tiopira- no)-piridinas
ES555529A Expired ES8801281A1 (es) 1984-05-10 1986-05-30 Procedimiento para la obtencion de benzo-(pirano y tiopirano)-piridinas
ES555530A Expired ES8801282A1 (es) 1984-05-10 1986-05-30 Procedimiento para la obtencion de benzo-(pirano y tiopirano)-piridinas
ES555528A Expired ES8801280A1 (es) 1984-05-10 1986-05-30 Procedimiento para la obtencion de benzo-(pirano y tiopirano)-piridinas
ES555527A Expired ES8801279A1 (es) 1984-05-10 1986-05-30 Procedimiento para la obtencion de benzo-(pirano y tiopirano)-piridinas

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ES542929A Expired ES8706687A1 (es) 1984-05-10 1985-05-08 Procedimiento para la obtencion de benzo-(pirano y tiopira- no)-piridinas
ES555529A Expired ES8801281A1 (es) 1984-05-10 1986-05-30 Procedimiento para la obtencion de benzo-(pirano y tiopirano)-piridinas
ES555530A Expired ES8801282A1 (es) 1984-05-10 1986-05-30 Procedimiento para la obtencion de benzo-(pirano y tiopirano)-piridinas

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES555527A Expired ES8801279A1 (es) 1984-05-10 1986-05-30 Procedimiento para la obtencion de benzo-(pirano y tiopirano)-piridinas

Country Status (20)

Country Link
US (1) US4604397A (es)
EP (1) EP0161218B1 (es)
JP (1) JPS60243090A (es)
AR (1) AR243526A1 (es)
AT (1) ATE64735T1 (es)
AU (1) AU592308B2 (es)
CA (1) CA1298582C (es)
DD (1) DD235872A5 (es)
DE (1) DE3583307D1 (es)
DK (1) DK168571B1 (es)
ES (5) ES8706687A1 (es)
FI (1) FI83652C (es)
GR (1) GR851116B (es)
HU (1) HU199476B (es)
IE (1) IE57978B1 (es)
IL (1) IL75135A (es)
NO (1) NO162860C (es)
NZ (1) NZ212031A (es)
PT (1) PT80415B (es)
ZA (1) ZA853507B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8426584D0 (en) * 1984-10-19 1984-11-28 Beecham Group Plc Compounds
US4666916A (en) * 1985-11-08 1987-05-19 Ciba-Geigy Corporation Hexahydro-(1)-benzo-(pyrano and thiopyrano) (4,3-C)pyridines, useful as serotin-2 blocking agents
US4792548A (en) * 1986-05-21 1988-12-20 Warner-Lambert Company Trans-benzopyran-(4,3-b)-1,4-oxazine derivatives, intermediates and pharmaceutical use
US4801605A (en) * 1986-08-29 1989-01-31 Ciba-Geigy Corporation 3-amino-dihydro-[1]-benzopyrans and benzothiopyrans
FR2619112B1 (fr) * 1987-08-07 1989-11-17 Synthelabo Derives de (piperidinyl-4)methyl-2 benzo(b)furo(2,3-c) pyridines, leur preparation et leur application en therapeutique
US4992465A (en) * 1988-09-27 1991-02-12 Ciba-Geigy Corporation 3-amino-dihydro-(1)-benzopyrans
US5962463A (en) * 1992-10-09 1999-10-05 Massachusetts Institute Of Technology Methods of stimulating non-amyloidogenic processing of the amyloid precursor protein
FR2721027B1 (fr) 1994-06-08 1996-07-19 Adir Nouveaux dérivés tétracycliques de la 1,4-oxazine, leur procédé de préparation et les compositions pharmaceutiques les contenant.
FR2741074B1 (fr) 1995-11-09 1997-12-19 Adir Nouveaux composes tetracycliques de la 1,4-oxazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6342533B1 (en) * 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
DE60039132D1 (de) * 1999-04-06 2008-07-17 Sepracor Inc O-Desmethylvenlafaxin-Succinat
WO2005032485A2 (en) * 2003-10-03 2005-04-14 Psychogenics, Inc. Compounds and methods for the treatment of attention-deficit hyperactivity disorder
AU2006265008A1 (en) * 2005-07-06 2007-01-11 Sepracor Inc. Combinations of eszopiclone and O-desmethylvenlafaxine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
BRPI1003506B1 (pt) 2010-09-24 2019-12-03 Ache Int Bvi Ltd composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143819A (es) * 1965-09-27
US3514464A (en) * 1967-05-29 1970-05-26 Little Inc A 5-oxo-1,2,3,4-tetrahydro-5h-(1)benzopyrano(3,4-c)pyridines
US3689497A (en) * 1971-03-09 1972-09-05 Warner Lambert Co Substituted benzopyrano (3,4-b) pyridines and process for their preparation
US3915996A (en) * 1972-10-16 1975-10-28 Abbott Lab Process for making benzopyrans
US4025630A (en) * 1973-09-19 1977-05-24 Abbott Laboratories Anesthesia methods using benzopyrans and esters thereof as pre-anesthesia medication
US4292316A (en) * 1978-10-02 1981-09-29 Abbott Laboratories Antiglaucoma agents
US4210758A (en) * 1979-03-21 1980-07-01 Warner-Lambert Company 1,5-Dihydro-1,5-dioxo-N-1H-tetrazol-5-yl-4H-[1]benzopyrano[3,4-b]pyridine-2-carboxamides
US4198511A (en) * 1979-03-21 1980-04-15 Warner-Lambert Company 1,5-Dihydro-1,5-dioxo-N-1H-tetrazol-5-yl-4H-[1]benzopyrano[3,4-b]pyridine-3-carboxamides and process thereof
JPS5746903A (en) * 1980-09-05 1982-03-17 Mitsubishi Chem Ind Ltd Agricultural and gardening fungicide
NL8005754A (nl) * 1980-10-18 1982-05-17 Akzo Nv Benzo 4,5 pyrano 2,3-c pyrrool derivaten.
US4420480A (en) * 1981-11-20 1983-12-13 Merck & Co., Inc. Hexahydronaphth[1,2-b]-1,4-oxazines
US4540691A (en) * 1984-04-13 1985-09-10 Nelson Research & Development Co. Dopamine agonists and use thereof
US4666916A (en) * 1985-11-08 1987-05-19 Ciba-Geigy Corporation Hexahydro-(1)-benzo-(pyrano and thiopyrano) (4,3-C)pyridines, useful as serotin-2 blocking agents

Also Published As

Publication number Publication date
ES8801281A1 (es) 1988-01-01
HUT37939A (en) 1986-03-28
DK168571B1 (da) 1994-04-25
ATE64735T1 (de) 1991-07-15
ES555529A0 (es) 1988-01-01
IL75135A0 (en) 1985-09-29
ES555528A0 (es) 1988-01-01
DK205285A (da) 1985-11-11
PT80415B (en) 1987-04-16
NO851846L (no) 1985-11-11
ES8801282A1 (es) 1988-01-01
US4604397A (en) 1986-08-05
EP0161218A2 (de) 1985-11-13
AU4224885A (en) 1985-11-14
ES542929A0 (es) 1987-07-01
ZA853507B (en) 1985-12-24
AU592308B2 (en) 1990-01-11
FI83652B (fi) 1991-04-30
FI851802L (fi) 1985-11-11
FI851802A0 (fi) 1985-05-08
ES555527A0 (es) 1988-01-01
DK205285D0 (da) 1985-05-09
EP0161218A3 (en) 1987-03-04
ES8801279A1 (es) 1988-01-01
HU199476B (en) 1990-02-28
IE851155L (en) 1985-11-10
EP0161218B1 (de) 1991-06-26
ES555530A0 (es) 1988-01-01
DE3583307D1 (en) 1991-08-01
NZ212031A (en) 1988-08-30
AR243526A1 (es) 1993-08-31
FI83652C (fi) 1991-08-12
IE57978B1 (en) 1993-06-02
GR851116B (es) 1985-11-25
NO162860B (no) 1989-11-20
CA1298582C (en) 1992-04-07
NO162860C (no) 1990-02-28
ES8706687A1 (es) 1987-07-01
PT80415A (en) 1985-06-01
JPH0443917B2 (es) 1992-07-20
JPS60243090A (ja) 1985-12-03
IL75135A (en) 1989-07-31
DD235872A5 (de) 1986-05-21

Similar Documents

Publication Publication Date Title
TW359672B (en) Thienopyrimidines ad phosphodiesterase V antagonists, process for the production thereof and pharmaceutical compositions containing the same
ES8801281A1 (es) Procedimiento para la obtencion de benzo-(pirano y tiopirano)-piridinas
BG103417A (en) Condensed pyrimidine bicyclic derivatives
YU40300A (sh) Aril fuzirana azapoliciklična jedinjenja
IL114003A (en) 1,4,6-Trisubstituted 1H-pyrrolo[2,3-b]pyridine and 1-H-pyrazolo[3,4-b] pyridine derivatives and pharmaceutical compositions containing them and some intermediates for their preparation
LU90283I2 (fr) Sporanox soluté buvable et ses dérivés pharmaceutiquement acceptables
HUT38256A (en) Process for producing combined pharmaceutical compositions containing xantine derivatives and o-acetyl-salicylic acid or pharmaceutically acceptables salts
HUT52040A (en) Process for producing diaryl-derivatives and pharmaceutical compositions containing them
ES8500247A1 (es) Un procedimiento para la preparacion de un isomero optico en su forma (-) de un derivado de triazina.
DE3566404D1 (en) Substituted benzopyrans, process for their preparation and their use in medicines
ES8605507A1 (es) Un compuesto de 3-indolcarboxamida
ES8308549A1 (es) Procedimiento para la preparacion de derivados de tiazolina.
AU658175B2 (en) Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients
ES8203380A1 (es) Un procedimiento de preparacion de 4-(1-piperazinil)-fu- ro(3,2-c)piridinas
IL83216A0 (en) Tetracyclic indole derivatives,their preparation and pharmaceutical compositions containing them
ES8308332A1 (es) Un procedimiento para la preparacion de nuevos derivados de fosfolipidos.
IL67400A (en) Octahydro-3,7a-diazacyclohepta(j,k)fluorene derivatives,their preparation and pharmaceutical compositions containing them
SE8802997L (sv) Aminderivat och dess salt, foerfarande foer framstaellning daerav och medel mot saar innehaallande desamma
ES455692A1 (es) Procedimiento para la produccion de derivados de alquilen- dioxipiperacina.
EP0324184A3 (en) 2-amino-1,2,3,4-tetrahydroisoquinoline derivatives, method for their preparation and their use as medicines
IL99782A0 (en) Ergoline derivatives,their production and pharmaceutical compositions containing them
GB1265643A (es)
GB1422831A (en) Acylaminobenzimidazole derivatives
FR2592653A1 (fr) Derives de chromene, procede d'obtention et compositions pharmaceutiques.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519